609 related articles for article (PubMed ID: 16446138)
1. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.
Ogier M; Wang H; Hong E; Wang Q; Greenberg ME; Katz DM
J Neurosci; 2007 Oct; 27(40):10912-7. PubMed ID: 17913925
[TBL] [Abstract][Full Text] [Related]
3. Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice.
Kline DD; Ogier M; Kunze DL; Katz DM
J Neurosci; 2010 Apr; 30(15):5303-10. PubMed ID: 20392952
[TBL] [Abstract][Full Text] [Related]
4. Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice.
Li W; Calfa G; Larimore J; Pozzo-Miller L
Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17087-92. PubMed ID: 23027959
[TBL] [Abstract][Full Text] [Related]
5. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
6. A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome.
Kron M; Lang M; Adams IT; Sceniak M; Longo F; Katz DM
Dis Model Mech; 2014 Sep; 7(9):1047-55. PubMed ID: 25147297
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome.
Vogel Ciernia A; Yasui DH; Pride MC; Durbin-Johnson B; Noronha AB; Chang A; Knotts TA; Rutkowsky JR; Ramsey JJ; Crawley JN; LaSalle JM
Hum Mol Genet; 2018 Dec; 27(23):4077-4093. PubMed ID: 30137367
[TBL] [Abstract][Full Text] [Related]
8. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
9. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
10. Restoring Wnt6 signaling ameliorates behavioral deficits in MeCP2 T158A mouse model of Rett syndrome.
Hsu WL; Ma YL; Liu YC; Tai DJC; Lee EHY
Sci Rep; 2020 Jan; 10(1):1074. PubMed ID: 31974426
[TBL] [Abstract][Full Text] [Related]
11. Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway.
Roux JC; Zala D; Panayotis N; Borges-Correia A; Saudou F; Villard L
Neurobiol Dis; 2012 Feb; 45(2):786-95. PubMed ID: 22127389
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
13. Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling.
Miranda-Lourenço C; Duarte ST; Palminha C; Gaspar C; Rodrigues TM; Magalhães-Cardoso T; Rei N; Colino-Oliveira M; Gomes R; Ferreira S; Rosa J; Xapelli S; Armstrong J; García-Cazorla À; Correia-de-Sá P; Sebastião AM; Diógenes MJ
Neurobiol Dis; 2020 Nov; 145():105043. PubMed ID: 32798727
[TBL] [Abstract][Full Text] [Related]
14. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons.
Yazdani M; Deogracias R; Guy J; Poot RA; Bird A; Barde YA
Stem Cells; 2012 Oct; 30(10):2128-39. PubMed ID: 22865604
[TBL] [Abstract][Full Text] [Related]
15. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice.
Lonetti G; Angelucci A; Morando L; Boggio EM; Giustetto M; Pizzorusso T
Biol Psychiatry; 2010 Apr; 67(7):657-65. PubMed ID: 20172507
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice.
Wang H; Chan SA; Ogier M; Hellard D; Wang Q; Smith C; Katz DM
J Neurosci; 2006 Oct; 26(42):10911-5. PubMed ID: 17050729
[TBL] [Abstract][Full Text] [Related]
17. Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of
Miranda-Lourenço C; Rosa J; Rei N; Belo RF; Lopes AL; Silva D; Vieira C; Magalhães-Cardoso T; Viais R; Correia-de-Sá P; Sebastião AM; Diógenes MJ
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003438
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice.
Ehinger Y; Bruyère J; Panayotis N; Abada YS; Borloz E; Matagne V; Scaramuzzino C; Vitet H; Delatour B; Saidi L; Villard L; Saudou F; Roux JC
EMBO Mol Med; 2020 Feb; 12(2):e10889. PubMed ID: 31913581
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
20. Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice.
Vermehren-Schmaedick A; Jenkins VK; Knopp SJ; Balkowiec A; Bissonnette JM
Neuroscience; 2012 Mar; 206():1-6. PubMed ID: 22297041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
